January 22, 2015 | The Australian medical cannabis company PhytoTech Medical has become the first medical marijuana company on the Australian Securities Exchange (ASX). The company, which as a research center in Israel and is partnered with Hebrew University’s Yissum technology transfer company, raised AUS$5.9 million dollars (approx. US$4.7 million) at a share price of $0.20 per share. PhytoTech’s core focus in the growing medical cannabis market is on the research, development and commercialization of cannabis products for the treatment of various medical conditions. PhytoTech has an exclusive research and licensing agreement with Yissum.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Non-Profit Launches 10M Shekel Fund For Israeli Small Businesses
December 06, 2023

Amid War, Program Helps Open US Doors For 10 Israeli Startups
December 06, 2023

Israeli Data Privacy Startup Raises $30M in Wartime
December 05, 2023

Israel Awards ‘World’s First’ License For Drone Flights
December 05, 2023
Facebook comments